RecruitingHematologic MalignanciesInherited Disorders of MetabolismInherited Abnormalities of Platelets
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Eligible age
All ages
Accepts
All genders
Locations
41 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.
Sponsor: Center for International Blood and Marrow Transplant Research
You may qualify if…
- ✓ Disorders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment
- ✓ Signed informed consent (and signed assent, if applicable) obtained prior to study enrollment
- ✓ Pediatric and adult patients of any age
You may not qualify if…
- ✕ Patients who are receiving only licensed CBUs
- ✕ Cord blood transplant recipients at international transplant centers
- ✕ Patients who are enrolled on another IND protocol to access the unlicensed CBU(s)
- ✕ Patients whose selected unlicensed CBU(s) will be more than minimally manipulated
Where it's recruiting
Alabama
Birmingham
Arizona
Gilbert · Phoenix · Tucson
Arkansas
Little Rock
California
Duarte · Glendale · La Jolla · Loma Linda …
Colorado
Aurora · Denver
Connecticut
New Haven
Delaware
Brandywine
District of Columbia
Washington D.C.
Florida
Gainesville · Jacksonville · Miami · Orlando …
Georgia
Atlanta · Augusta
Hawaii
Honolulu
Illinois
Chicago · Maywood · Park Ridge · Zion
Source: ClinicalTrials.gov · NCT01351545 · last updated 2026-07-06